Nightmare Disorder
Nightmare disorder, also known as dream anxiety disorder, is a sleep disorder characterized by frequent nightmares. The nightmares, which often portray the individual in a situation that jeopardizes their life or personal safety, usually occur during the REM stages of sleep.
Cluster Number:
Wiki Number: PW136
Diagnosis: Nightmare Disorder
US Patients: 4% of adults; 1% of children
World Patients:
Sex Ratio: M;W2
Age Onset:
Brain Area:
Symptoms: frequent nightmares involving personal safety, usually occurring during REM stages of sleep; remembers every detail of the dream
Progression: does not wake up screaming, but reduce daytime efficiencies from being “tired”; fear and physical aggression are the most common
Causes: PTSD, extreme stress, death of a loved one; 30% have other psychiatric illnesses
Medications: several antipsychotic medicines have reduced nightmares; hypnosis and relaxation may also help
Therapies: EMDR (Eye Movement Desensitization and Reprocessing) have helped portions of those with PTSD or other threatening experiences.
Youtube Video: Nightmares and Treatment
Amazon or Library Book: Nightmareland
Click the book to link or buy from Amazon.
Support Group: sleepeducation.org; 630-737-9700
(American Academy of Sleep Medicine)
4 CURRENT ARTICLES
FROM PUBMED
The world-wide medical research
reports chosen for each diagnosis
Clicking each title opens the
PubMed article’s summary-abstract.
- Associations of Nightmares and Sleep Disturbance With Neurobehavioral Symptoms Postconcussionby Afik Faerman on May 6, 2024
CONCLUSIONS: Nightmares and sleep disturbance are differentially associated with variance in neurobehavioral symptoms. Nightmares were independently associated with neurobehavioral symptoms representing an excess of normal functioning (eg, anxiety, impulsivity), while general sleep disturbance was associated with neurobehavioral symptoms representing functioning below normal levels (eg, depression, fatigue, self-reported executive dysfunction). Clinical and research implications are discussed.
- Identification and validation of N-acetylputrescine in combination with non-canonical clinical features as a Parkinson's disease biomarker panelby Kuan-Wei Peng on May 1, 2024
Parkinson's disease is a progressive neurodegenerative disorder in which loss of dopaminergic neurons in the substantia nigra results in a clinically heterogeneous group with variable motor and non-motor symptoms with a degree of misdiagnosis. Only 3-25% of sporadic Parkinson's patients present with genetic abnormalities that could represent a risk factor, thus environmental, metabolic, and other unknown causes contribute to the pathogenesis of Parkinson's disease, which highlights the critical...
- Sleep Disorders in Patients with Severe COVID-19 Treated in the Intensive Care Unit: A Real-Life Descriptive Study in Vietnamby Sy Duong-Quy on April 26, 2024
CONCLUSION: Sleep problems are highly prevalence among hospitalized patients with severe COVID-19 in the ICU. Healthcare providers should pay attention to sleep problems and their associated symptoms to initiate appropriate treatment to improve severe COVID-19 patients' health status and minimize the risk of death.
- The mediation effects of nightmares and depression between insomnia and suicidal ideation in young adultsby Zixuan Guo on April 26, 2024
Suicide is prevalent among young adults, and epidemiological studies indicate that insomnia, nightmares, and depression are significantly associated with a high incidence of suicidal ideation (SI). However, the causal relationship between these factors and SI remains unclear. Therefore, the purpose of this study was to examine the association between nightmares and depression and insomnia and SI in young adults, as well as to develop a mediation model to investigate the causal relationship...